Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study
详细信息    查看全文
文摘
class="listitem" id="list_ulist0010">
class="label">•

Randomised Controlled Trial to study differences in health-related quality of life in curative intended prostate cancer patients after randomising androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor.

class="label">•

Mainly intermediate-risk group of prostate cancer patients were included at Radiumhemmet, Karolinska Univeristy Hospital, Sweden with a ratio of 1:1.

class="label">•

Two European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaires were used (EORTC QLQ C-30 + EORTC QLQ PR25).

class="label">•

Better sexual interset was noted in patients treated with androgen receptor inhibitor monotherapy compared to castration plus an androgen receptor inhibitor at 3 and 18-month follow-up assessments.

class="label">•

Study was not powered enough to address on overall survival due to relatively small sample size and shorter follow-up time.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700